Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Aneurysm II: Clinical Manifestations and Diagnostic Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 16, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
G Giussani1, E Bianchi1, C M Bonardi2
1Laboratory of Neurological Disease, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
Anakinra treatment for cryptogenic new-onset refractory status epilepticus (cNORSE) showed no long-term neurological benefit, despite its use in intensive care. Further trials are needed to confirm its efficacy and role in treating this neurological emergency.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: